Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Viatris Promises Clarity And Certainty On $9bn Transformation Plans
As Company Sticks With 2022 FY Guidance Following Q1 Financials
May 10 2022
•
By
Dean Rudge
Viatris says it is aware of concerns over clarity • Source: Shutterstock
More from Earnings
More from Business